Herbal Medicines for Ischemic Stroke: Combating Inflammation as Therapeutic Targets

被引:0
作者
Yong Gu
Jianping Chen
Jiangang Shen
机构
[1] The University of Hong Kong,School of Chinese Medicine, LKS Faculty of Medicine
[2] The University of Hong Kong,Research Centre of Heart, Brain, Hormone & Healthy Aging
来源
Journal of Neuroimmune Pharmacology | 2014年 / 9卷
关键词
Inflammation; Ischemic stroke; Neuroprotection; Herbal medicine; Inflammatory factors;
D O I
暂无
中图分类号
学科分类号
摘要
Stroke is a debilitating disease for which limited therapeutic approaches are available currently. Thus, there is an urgent need for developing novel therapies for stroke. Astrocytes, endothelial cells and pericytes constitute a neurovascular network for metabolic requirement of neurons. During ischemic stroke, these cells contribute to post-ischemic inflammation at multiple stages of ischemic cascades. Upon ischemia onset, activated resident microglia and astrocytes, and infiltrated immune cells release multiple inflammation factors including cytokines, chemokines, enzymes, free radicals and other small molecules, not only inducing brain damage but affecting brain repair. Recent progress indicates that anti-inflammation is an important therapeutic strategy for stroke. Given a long history with direct experience in the treatment of human subjects, Traditional Chinese Medicine and its related natural compounds are recognized as important sources for drug discovery. Last decade, a great progress has been made to identify active compounds from herbal medicines with the properties of modulating post-ischemic inflammation for neuroprotection. Herein, we discuss the inflammatory pathway in early stage and secondary response to injured tissues after stroke from initial artery occlusion to brain repair, and review the active ingredients from natural products with anti-inflammation and neuroprotection effects as therapeutic agents for ischemic stroke. Further studies on the post-ischemic inflammatory mechanisms and corresponding drug candidates from herbal medicine may lead to the development of novel therapeutic strategies in stroke treatment.
引用
收藏
页码:313 / 339
页数:26
相关论文
共 1541 条
[1]  
Abulafia DP(2009)Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice J Cereb Blood Flow Metab 29 534-544
[2]  
de Rivero Vaccari JP(2013)Microglia: scapegoat, saboteur, or something else? Science 339 156-161
[3]  
Lozano JD(2002)Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase Biochem Pharmacol 64 1767-1775
[4]  
Lotocki G(2006)Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus Eur J Pharm 543 40-47
[5]  
Keane RW(2012)Nerve growth factor: from the early discoveries to the potential clinical use J Transl Med 10 239-244
[6]  
Dietrich WD(2002)Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats Neurobiol Dis 9 187-204
[7]  
Aguzzi A(2013)SnapShot: inflammasomes Cell 153 e271-4278
[8]  
Barres B(2013)Free energy landscape for the binding process of huperzine a to acetylcholinesterase Proc Natl Acad Sci U S A 110 4273-1244
[9]  
Bennett ML(1997)Tumor necrosis factor-alpha - a mediator of focal ischemic brain injury Stroke 28 1233-5014
[10]  
Albert D(2012)Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury J Neuroinflammation 9 191-5534